These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3244986)

  • 1. Value of Locabiotal Aerosol in rhinosinusitis.
    Cuénant G
    Rhinol Suppl; 1988; 5():69-74. PubMed ID: 3244986
    [No Abstract]   [Full Text] [Related]  

  • 2. [The assessment of bioparox efficiency in therapy of acute rhinosinusitis].
    Mashkova TA
    Vestn Otorinolaringol; 2005; (3):64-5. PubMed ID: 16034354
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bioparox in the treatment of sinusitis].
    Gadzhiev MK
    Vestn Otorinolaringol; 2001; (4):54. PubMed ID: 11530484
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
    Klossek JM
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of rhinosinusitis with fusafungine nasal spray. A double-blind, placebo-controlled, parallel-group study in 20 patients.
    Mösges R; Spaeth J; Berger K; Dubois F
    Arzneimittelforschung; 2002; 52(12):877-83. PubMed ID: 12572527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of fusafungine anti-inflammatory activity by rhinomanometry.
    Ghaem A; Harpey C
    Rhinol Suppl; 1988; 5():63-8. PubMed ID: 3244985
    [No Abstract]   [Full Text] [Related]  

  • 7. Local treatment of upper respiratory tract conditions. Role of Locabiotal Aerosol (fusafungine). Proceedings of an international meeting. Athens, April 28-May 1, 1988.
    Rhinol Suppl; 1988; 5():1-79. PubMed ID: 3244979
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial.
    Desrosiers MY; Salas-Prato M
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):265-9. PubMed ID: 11555764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioparox in therapy of acute rhinosinusitis].
    Kozlov VS
    Vestn Otorinolaringol; 2005; (5):44-6. PubMed ID: 16247369
    [No Abstract]   [Full Text] [Related]  

  • 10. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study.
    Liang KL; Su MC; Shiao JY; Tseng HC; Hsin CH; Lin JF; Jiang RS
    Am J Rhinol; 2008; 22(1):52-8. PubMed ID: 18284860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric sinusitis and surgery revisited.
    Poole MD
    Ear Nose Throat J; 1993 Apr; 72(4):259-60. PubMed ID: 8486104
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.
    Wallwork B; Coman W; Mackay-Sim A; Greiff L; Cervin A
    Laryngoscope; 2006 Feb; 116(2):189-93. PubMed ID: 16467702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
    Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.
    Ponikau JU; Sherris DA; Weaver A; Kita H
    J Allergy Clin Immunol; 2005 Jan; 115(1):125-31. PubMed ID: 15637558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of a new immunotherapy with an aerosol for rhinopharyngeal diseases in children].
    Pialoux P; Danon J
    Ann Otolaryngol Chir Cervicofac; 1971 Dec; 88(12):685-9. PubMed ID: 5150490
    [No Abstract]   [Full Text] [Related]  

  • 16. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
    Marple BF; Roberts CS; de Caprariis PJ; Reisman A
    Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioparox effects on nasal mucosa in acute catarrhal rhinosinusitis].
    Kozlov VS; Shilenkova VV; Derzhavina LL; Kramnoĭ AI
    Vestn Otorinolaringol; 2007; (4):45-8. PubMed ID: 17828114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of bioparox treatment in acute inflammatory diseases of the upper airways].
    Luchikhin LA; Buianovskaia OA; Derevianko SN; Paukova MV
    Vestn Otorinolaringol; 1996; (2):38-42. PubMed ID: 8711845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective and subjective evaluation of endoscopic nasal surgery outcomes.
    Giger R; Landis BN; Zheng C; Malis DD; Ricchetti A; Kurt AM; Morel DR; Lacroix JS
    Am J Rhinol; 2003; 17(6):327-33. PubMed ID: 14750607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities of using bioparox in the treatment of patients with diseases of the upper airways].
    Ovchinnikov IuM; Svishtushkin VM; Nikiforova GN; Iarin IuM; Morozova OA
    Vestn Otorinolaringol; 1996; (3):56-7. PubMed ID: 8928384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.